Publicacións nas que colabora con Jordi Xercavins Montosa (25)

2012

  1. Location of aortic node metastases in locally advanced cervical cancer

    Gynecologic Oncology, Vol. 125, Núm. 2, pp. 312-314

  2. Risk factors for progression or persistence of squamous intraepithelial lesions diagnosed during pregnancy

    Journal of Lower Genital Tract Disease, Vol. 16, Núm. 1, pp. 34-38

2011

  1. Pretherapeutic extraperitoneal laparoscopic staging of bulky or locally advanced cervical cancer

    Annals of Surgical Oncology, Vol. 18, Núm. 2, pp. 482-489

2010

  1. Total laparoscopic radical hysterectomy for cervical cancer in prolapsed uterus

    Archives of Gynecology and Obstetrics, Vol. 282, Núm. 1, pp. 63-67

2008

  1. Microinvasive carcinoma of the cervix. Management of a neoplasm with favorable prognosis

    Progresos en Obstetricia y Ginecologia, Vol. 51, Núm. 4, pp. 209-214

2007

  1. Apoptosis in epithelial ovarian tumours. Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax)

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 130, Núm. 1, pp. 121-128

  2. ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer

    Cancer Research, Vol. 67, Núm. 14, pp. 6753-6759

  3. Modified approach for extraperitoneal laparoscopic staging for locally advanced cervical cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 26, Núm. 4, pp. 451-458

  4. Molecular determinants of invasion in endometrial cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 5, pp. 272-277

2006

  1. Ephrin B expression in epithelial ovarian neoplasms correlates with tumor differentiation and angiogenesis

    Human Pathology, Vol. 37, Núm. 7, pp. 883-889

  2. Molecular pathology of endometrial carcinoma: Transcriptional signature in endometrioid tumors

    Histology and Histopathology, Vol. 21, Núm. 1-3, pp. 197-204

  3. The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma

    Human Pathology, Vol. 37, Núm. 8, pp. 1050-1057

2005

  1. Endometrial cancer in polyps: A clinical study of 27 cases

    European Journal of Gynaecological Oncology, Vol. 26, Núm. 1, pp. 55-58

  2. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma

    Journal of Pathology, Vol. 207, Núm. 4, pp. 422-429

2004

  1. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma

    Cancer Research, Vol. 64, Núm. 24, pp. 8846-8853

2001

  1. Minimally deviated adenocarcinoma (malignant adenoma) of the cervix uteri

    Ginecología y obstetricia de México, Vol. 69, pp. 82-87

1999

  1. Clinicopathologic features and genetic alterations in endometrioid carcinoma of the uterus with villoglandular differentiation

    American Journal of Clinical Pathology, Vol. 111, Núm. 3, pp. 336-342

  2. Endometrial carcinoma in tamoxifen-treated breast cancer patient: Clinicopathological, immunohistochemical, and genetic analysis

    International Journal of Gynecological Pathology, Vol. 18, Núm. 4, pp. 387-391

1998

  1. Ovarian germ cell tumors

    European Journal of Gynaecological Oncology, Vol. 19, Núm. 2, pp. 130-134

1997

  1. Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart

    Laboratory Investigation, Vol. 76, Núm. 1, pp. 109-116